The 2018 oncology drug market had a record number of new treatments and continued a trend of growth.
Health System News
NHE3 inhibitor administered as 50 mg oral tablets.
New medications and treatment guidelines
Patients are still allowed to take medicines as prescribed.
Fentanyl, oxymorphone, and hydrocodone face greatest cuts.
Eight pharmacy groups lauded a letter urging the Trump administration to reform direct and indirect remuneration (DIR) fees.
Current phase 3 studies investigative novel, preventative approaches.
Investigational oral MET kinase inhibitor from Merck.
The age indication for some influenza vaccines has been expanded.
New changes are making it more difficult for generics and biosimilars to compete on formularies.